- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | HistoSonics enrolls first patients in histotripsy master study | ||
| Mo | iRhythm highlights clinical and economic benefits of Zio monitoring | ||
| Mo | BrightHeart earns FDA clearance for AI-powered prenatal heart ultrasound tech | ||
| Mo | Zimmer Biomet wins CE mark for Persona Knee | ||
| Mo | Boston Scientific Watchman FLX demonstrates superiority to anticoagulants in study | ||
| Mo | Abbott opens new FreeStyle Libre manufacturing plant in Ireland | ||
| Fr | Trump taps RFK Jr. to run HHS - but two groups could block him | ||
| Fr | Stryker sells former headquarters site for $3.5M | ||
| Fr | Boston Scientific finalizes $3.7B acquisition of Axonics | ||
| Fr | Investors urge Smith+Nephew to consider break-up over orthopedics performance | ||
| 14.11. | Tivic completes enrollment in nerve stim trial | ||
| 14.11. | Stryker rolls out next-gen SurgiCount+ hospital workflow tech | ||
| 14.11. | Hexagon Health sues Medtronic for alleged patent infringement of hernia mesh device | ||
| 14.11. | Solventum launches first 3D-printed dental aligner attachments | ||
| 14.11. | Eko picks up reimbursement win for AI heart disease detection platform | ||
| 14.11. | Johnson & Johnson MedTech inks distro deal to expand soft tissue solutions | ||
| 14.11. | What diabetes tech companies are doing on World Diabetes Day 2024 | ||
| 13.11. | ZAP Surgical Systems raises $78M for radiosurgery platform | ||
| 13.11. | Vicarious Surgical says first surgical robot trials remain on track, analysts remain neutral | ||
| 13.11. | Otsuka partners with ICU Medical to enter U.S. IV products market | ||
| 13.11. | Vascular stent graft maker Solaris Endovascular launches to address vascular health challenges | ||
| 13.11. | FDA clears outpatient cardiac telemetry for SmartCardia ECG patch | ||
| 13.11. | Zimmer Biomet names Arnold Schwarzenegger chief movement officer | ||
| 13.11. | GE HealthCare wins FDA nod for new head-only MRI system | ||
| 13.11. | FDA Commissioner Dr. Robert Califf weighs in on Trump's election as he plans his own exit: 'Stand by the people' |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
